TCG Crossover
Overview
TCG Crossover is a science-driven investment firm focused on the healthcare sector. The company invests in private and public companies and supports visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines. With offices in Palo Alto, San Francisco, and New York City, they have global capabilities and have supported companies in North America, Europe, and China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TriGemX Bio | Oct 2026 | Early Funding | Lead |
| CG Oncology | Aug 2023 | Crossover Round | Lead |
| Aktis Oncology | Sep 2024 | Series B | Co-investor |
| Obsidian Therapeutics | Apr 2026 | Private Equity | Co-investor |
| Maze Therapeutics | Sep 2025 | Private Placement | Co-investor |
For institutional investors. Book with your work email.
Key People
Giuliano Marostica
Managing Partner
Dandan Dong
Venture Partner
Cariad Chester
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is TCG Crossover based?
TCG Crossover is headquartered in Palo Alto, California, United States.
When was TCG Crossover founded?
TCG Crossover was founded in 2020.
How many portfolio companies does TCG Crossover have?
TCG Crossover has 37 portfolio companies in Caplight's dataset.
What are some companies in TCG Crossover's portfolio?
Portfolio companies visible on Caplight include TriGemX Bio, CG Oncology, Aktis Oncology, Obsidian Therapeutics, Maze Therapeutics.
What was TCG Crossover's most recent investment shown here?
TCG Crossover's most recent investment in this portfolio sample was in TriGemX Bio in 2026.
What sectors does TCG Crossover focus on?
TCG Crossover focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does TCG Crossover focus on?
TCG Crossover typically invests at the Mid stage.
What is TCG Crossover's AUM?
TCG Crossover's assets under management are estimated between $1.0B and $10.0B.